DHSC launches world’s largest COVID-19 trial

The Department of Health and Social Care (DHSC) has announces a national trial for treatments against the current pandemic coronavirus.

“A number” of treatments are included in the study to establish which may be effective against the virus. Evidence will be generated to decide which, if any, can be provided to patients. Selected treatments include:

  • Lopinavir-Ritonavir, commonly used to treat HIV
  • Dexamethasone, a type of steroid use in a range of conditions to reduce inflammation
  • Hydroxychloroquine, a treatment for malaria

DHSC said 132 hospital and almost 1,000 patients had been recruited for the study so far, named Randomised Evaluation of COVID-19 Therapy (RECOVERY).

Matt Hancock, Secretary of State for Health and Social Care, said:

“The coronavirus outbreak is the biggest public health emergency in a generation and we are doing everything we can to fight it on all fronts through our evidence-based action plan.

“The UK is leading the way on research in the race to find treatments and we have now launched the largest trial in the world, pooling resources with our world-leading life science sector.

“As one of three major trials funded by the government, this marks a major milestone in our battle against coronavirus and offers renewed hope that together we can beat this.

“The public still has a crucial role to play by staying at home so we can protect the NHS and save lives.”

Read the DHSC press release on the trial here.

Tagged with

Published on 6. April 2020 in News, News UK, Press Release